BMAL1 and metabolic syndrome: Bmal1 mutant mice also have disrupted circadian rhythmicity (Bunger et al. 2000), disrupted adipogenesis (Shimba et al. 2005), and demonstrate markers of metabolic syndrome (e.g., higher levels of triglycerides and glucose) (Marcheva et al. 2010; Rudic et al. 2004).